10x Health System

The question every serious franchise investor must answer before committing six figures to a health and wellness concept is not whether the industry is growing — it clearly is — but whether a specific brand has the differentiated model, financial structure, and operational depth to justify the risk. 10x Health System entered the market with a bold answer to that question. Co-founded by a high-profile team including real estate and business mogul Grant Cardone, entrepreneur and Chairman Brandon Dawson, and Chief Human Biologist Gary Brecka, the company launched its first clinic in Aventura, Florida in May 2022, staking its claim as a next-generation precision wellness brand built on personalized, data-driven health protocols rather than the generic supplement-and-fitness approach that has defined the wellness space for decades. The founding thesis was direct: conventional medicine treats disease after it appears, while 10x Health System targets optimization before decline sets in, using precision genetic testing, comprehensive blood analysis across more than 70 biomarkers, hormone optimization, IV nutrient therapy, peptide treatments, and the proprietary Superhuman Protocol, which applies magnetism, oxygen, and light to accelerate human performance. The company has since grown to seven total locations, all currently company-owned, with a footprint spanning Florida markets including Aventura and Naples, Scottsdale in Arizona, California, and international centers in London and Dubai, establishing a global brand presence that few wellness franchises at this stage of development have achieved. Operating within the U.S. healthcare spending ecosystem, which totals $4.3 trillion annually, 10x Health System has positioned itself inside the precision wellness sub-sector, where personalized, biomarker-driven care commands premium pricing and builds deep consumer loyalty. This analysis is an independent assessment produced for franchise investors conducting rigorous due diligence, and it draws exclusively on publicly disclosed financial data, Franchise Disclosure Document filings, and verifiable market research.

The industry backdrop for a 10x Health System franchise investment is arguably one of the most favorable in the entire franchise landscape right now. Healthcare franchise expansion is projected to accelerate significantly through 2026, with total healthcare franchise units projected to exceed 15,000 nationwide, annual unit growth rates estimated at 12 to 18 percent across categories, and revenue growth in the sector projected at 20 to 25 percent annually, driven primarily by demographic expansion. The demographic engine behind these numbers is structural and decades-long: over 54 million Americans are expected to reach age 65 or older by 2030, approximately 10,000 Baby Boomers turn 65 every single day through that same year, and the 85-plus population is currently the fastest-growing age cohort in the country, expanding at a rate of 3.2 percent annually. These consumers are not passive patients waiting for chronic illness to arrive — they are active, affluent, and willing to invest in preventive and performance-oriented health solutions, which is precisely the service category 10x Health System occupies. Within specialized medical services specifically, the sub-sector in which precision genetics, hormone optimization, and IV therapy sit, growth projections range from 120 to 180 percent, making it one of the most aggressively expanding segments in the entire healthcare franchise universe. Consumer demand is also being shaped by a broader cultural shift toward preventive and holistic care, with the traditional sick-care model losing credibility among health-conscious demographics who increasingly want access to the biomarker insights and customized protocols that were previously available only to elite athletes and wealthy individuals. The competitive landscape within precision wellness remains relatively fragmented at the franchise level, meaning early-mover franchisees in underserved markets have a genuine opportunity to establish market leadership before consolidation occurs, a window that historically closes quickly once a category attracts institutional franchise capital.

The 10x Health System franchise cost structure begins with an initial franchise fee of $100,000, paid upfront at the time of signing the Franchise Agreement. For context, this fee sits at the higher end of the wellness franchise category but reflects the premium positioning and specialized medical service delivery model that differentiates 10x Health System from lower-cost fitness or supplement retail concepts. The total estimated initial investment required to open a 10x Health System franchise ranges from approximately $216,000 to $523,400, with some buildout scenarios reaching up to $778,600 depending on market, location, and scope of leasehold improvements. The spread within that investment range is driven by several variables: leasehold improvements range from $15,000 to $95,000 depending on the condition of the space, medical equipment costs span from $10,000 to $150,000 depending on the full suite of services offered, and rent deposits for three months can range from $12,000 to $20,000 depending on market. Additional investment line items include fixtures and furniture between $15,500 and $35,000, training expenses of $2,500 to $4,000, computer systems between $2,500 and $5,000, grand opening marketing fixed at $10,000, signage from $4,000 to $6,000, professional fees from $1,000 to $10,000, and additional working capital funds of $30,000 to $50,000 for the early operating period. The minimum liquid capital requirement is $215,700. Notably, the midpoint of the 10x Health System franchise investment range is meaningfully lower than the sub-sector average of $395,825 to $685,317, which means investors are accessing a premium brand at a below-average entry cost relative to comparable specialized medical service franchises. Ongoing fees include a royalty rate of 12 percent of gross revenues, which is on the higher end of the franchise spectrum and reflects the extensive proprietary systems, medical protocols, and celebrity co-founder brand equity embedded in the model, plus a national brand fund contribution of 3 percent of gross revenues, bringing total ongoing fees to 15 percent of top-line revenue before any local marketing spend.

The daily operating reality of a 10x Health System franchise centers on delivering a clinical-grade personalized wellness experience that requires both medical staff and business operations personnel. The service menu — spanning genetic testing, blood analysis, IV therapy administration, hormone protocols, peptide treatments, and Superhuman Protocol sessions — demands a team that blends licensed medical professionals with client-facing wellness coaches and administrative staff. Training is structured around the proprietary IV Academy, which comprises 18 distinct educational modules backed by hundreds of high-quality expert-led videos covering IV therapy, genetic testing, blood analysis interpretation, and Superhuman Protocol delivery. Franchisees also receive access to Grant Cardone's 10X Sales Training system and Brandon Dawson's Growth and Scaling Business Systems, two high-profile proprietary methodologies that address the revenue generation and operational scaling challenges that commonly derail early-stage wellness franchises. Corporate support extends to ongoing operational guidance, access to the latest advances in wellness technology and treatment protocol updates, and dedicated rebranding support packages for existing health businesses converting to the 10x Health System format, which represents an accelerated pathway to opening for operators who already manage medical real estate and clinical staff. The company explicitly emphasizes having the full 10x team supporting franchisees at every stage of development, and the leadership bench — which includes President Kent Bradley, Chief Revenue Officer Jeremy Gabbert, and Chief Marketing Officer Will Sliger alongside the co-founding team — provides a multi-disciplinary support structure that extends beyond the typical franchise operations department. Co-Founder and Chief Marketing Officer Carrie Brecka leads brand development, while Co-Founder and CBO Natalie Dawson manages business operations at the corporate level, giving franchisees access to a leadership team with combined expertise spanning medicine, marketing, sales, and scaling.

Item 19 financial performance data is not disclosed in the current Franchise Disclosure Document for 10x Health System, and the FDD lists profit as undisclosed. This is a material consideration for any franchise investor conducting rigorous unit economics analysis, and it means that return-on-investment modeling must rely on external data points rather than franchisor-provided performance figures. With that transparency caveat clearly stated, publicly available revenue analysis paints a compelling picture of the brand's current revenue performance. A 10x Health System franchised location generates an average of $3,008,000 in annual revenue per unit, a figure that substantially outperforms the sub-sector average of approximately $1.22 million per year. One analysis of the brand's gross revenue performance reported a figure of $7.95 million, which is roughly 6.5 times the sub-sector average and suggests that the company's existing locations are operating at a significant revenue premium relative to comparable wellness concepts. These revenue figures must be evaluated with appropriate caution — revenue is not profit, and the 12 percent royalty plus 3 percent brand fund represents 15 percent of the top line going back to the franchisor before labor, rent, supplies, insurance, and equipment costs are accounted for. The absence of Item 19 disclosure means investors cannot independently verify cost structures, owner compensation, or net operating margins from the FDD, which makes thorough third-party due diligence, including conversations with existing franchisees and analysis of comparable medical wellness clinic economics, essential before signing. The revenue benchmark data that is available, however, positions 10x Health System among the highest-revenue wellness franchise concepts in its size category, and for investors whose primary unit economics question is whether demand exists to support premium pricing, the publicly available revenue data offers an encouraging signal. Healthcare franchise revenue growth is projected at 20 to 25 percent annually through demographic-driven expansion, which provides a macro tailwind that may support continued revenue growth at the unit level as brand awareness scales.

The 10x Health System franchise growth story is early-stage by any measure, which simultaneously represents its most compelling opportunity and its most significant risk factor. The company launched its first location in May 2022 and has since expanded to seven total locations, all currently company-owned, with no franchised units reported as operational as of the most recent assessment, though several units are described as in active development. The absence of operational franchised units means investors considering the 10x Health System franchise opportunity would be entering as early adopters — a position that historically rewards franchisees with advantaged territory selection and the ability to establish local market dominance before the brand saturates a region, but that also means there is a limited track record of franchisee-level operational performance to analyze. The brand's international presence in London and Dubai, combined with its domestic multi-market footprint across Florida, Arizona, and California, demonstrates that the corporate model has been validated beyond a single-market proof of concept, which is a meaningful development milestone for a brand of this age. Corporate development is supported by the involvement of Cardone Ventures as an investor and the personal capital and brand infrastructure of Grant Cardone, whose 10X brand ecosystem gives 10x Health System access to an existing audience of entrepreneurially minded, performance-focused consumers who align precisely with the brand's target demographic. The Superhuman Protocol — using pulsed electromagnetic field therapy, hyperbaric-grade oxygen delivery, and photobiomodulation light therapy in a structured three-phase protocol — serves as the brand's primary competitive differentiator and proprietary technology moat, creating a service experience that requires both specialized equipment and trained practitioners and is therefore difficult for independent wellness operators to replicate at scale. Leadership appears stable as of April 2025, with co-founders Gary Brecka, Sage Workako, and Carrie Brecka holding active operational roles, and a full executive bench including Chief Revenue Officer Jeremy Gabbert and President Kent Bradley providing the corporate infrastructure needed to support franchise system growth.

The ideal 10x Health System franchisee is not a passive investor seeking an absentee income stream. The complexity of the service model — which spans licensed medical delivery, precision diagnostics, and high-touch client relationship management — calls for a franchise owner who is either from a healthcare, wellness, or executive business operations background, or who is capable of recruiting and managing the specialized clinical and sales staff that the model requires. Franchisees gain access to the full 10x training ecosystem, including the IV Academy's 18-module curriculum and the Cardone-Dawson business scaling methodologies, which means prior wellness industry experience is not a prerequisite, but strong management acumen and a commitment to the owner-operator or engaged owner model is essential for driving the revenue performance that the brand's publicly reported averages suggest is achievable. Geographic expansion targets include markets across the United States, with the company's stated plan to open centers nationally, making available territories broadly accessible at this early stage of system development. The brand's existing footprint in Florida, Arizona, and California, along with international presence in London and Dubai, suggests that both major metropolitan markets and affluent secondary markets are viable targets, as the core demographic — health-conscious, performance-oriented, and willing to invest in personalized wellness — is geographically distributed rather than concentrated in a single region. Investors evaluating territory selection should prioritize markets with high concentrations of the 45-to-70 age demographic, above-median household income, and existing consumer familiarity with concierge health services, as these variables historically correlate with premium wellness spending at the unit level.

Any serious analysis of the 10x Health System franchise opportunity must ultimately answer the investor's core question: does the combination of brand differentiation, revenue potential, market timing, and total investment justify committing $216,000 to $523,400 or more in a category where financial performance data is not fully disclosed? The investment thesis rests on several compounding factors: a $4.3 trillion U.S. healthcare market with specialized medical services growing at 120 to 180 percent annually, a proprietary service model that is genuinely difficult to replicate independently, publicly reported average unit revenue of $3,008,000 that substantially outperforms the $1.22 million sub-sector average, a total investment range that sits below the category average despite the premium brand positioning, and co-founder brand equity that gives the franchise a consumer marketing reach most emerging wellness brands cannot access at any price. The offsetting considerations are equally important to weight: the 12 percent royalty plus 3 percent brand fund creates a 15 percent top-line commitment that is among the highest in the franchise universe, profit margins are not disclosed, and the franchise system has no confirmed operational franchised locations yet, meaning investors are evaluating potential based on corporate unit performance rather than franchisee-proven replication. These are not disqualifying factors, but they are facts that require thorough independent investigation. PeerSense provides exclusive due diligence data including SBA lending history, FPI score, location maps with Google ratings, FDD financial data, and side-by-side comparison tools that allow investors to benchmark the 10x Health System franchise against competing concepts across every relevant financial and operational dimension. Explore the complete 10x Health System franchise profile on PeerSense to access the full suite of independent franchise intelligence data.